M, P., KT, M., C, Y., JG, B., 4th, B. F., MR, P., . . . Hoff, S. J. (2012). Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery. Critical Care Medicine, 40(10), 2805. https://doi.org/10.1097/ccm.0b013e31825b8be2
Chicago Style (17th ed.) CitationM, Pretorius, et al. "Angiotensin-converting Enzyme Inhibition or Mineralocorticoid Receptor Blockade Do Not Affect Prevalence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery." Critical Care Medicine 40, no. 10 (2012): 2805. https://doi.org/10.1097/ccm.0b013e31825b8be2.
MLA (9th ed.) CitationM, Pretorius, et al. "Angiotensin-converting Enzyme Inhibition or Mineralocorticoid Receptor Blockade Do Not Affect Prevalence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery." Critical Care Medicine, vol. 40, no. 10, 2012, p. 2805, https://doi.org/10.1097/ccm.0b013e31825b8be2.